May 23, 2022

Public workspaceLRRK2RCKW single molecule kinesin motility assays

  • 1Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093
Icon indicating open access to content
QR code linking to this content
Protocol CitationJohn Salogiannis 2022. LRRK2RCKW single molecule kinesin motility assays. protocols.io https://dx.doi.org/10.17504/protocols.io.ewov14qykvr2/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it’s working
Created: November 28, 2020
Last Modified: May 31, 2024
Protocol Integer ID: 44969
Keywords: LRRK2, motility assay, kinesin, imaging, single-molecule, ASAPCRN
Abstract
This protocol is about LRRK2RCKW single molecule kinesin motility assays.
Guidelines
As used in:
CITATION
Deniston CK, Salogiannis J, Mathea S, Snead DM, Lahiri I, Matyszewski M, Donosa O, Watanabe R, Böhning J, Shiau AK, Knapp S, Villa E, Reck-Peterson SL, Leschziner AE (2020). Structure of LRRK2 in Parkinson's disease and model for microtubule interaction.. Nature.

Image Recommendation:
Settings will vary per microscope. We imaged K560-GFP every 500 msecs for 2 mins with 25% laser (488) power at 150 ms exposure time. Each sample was imaged no longer than 15 mins. Each technical replicate recommended to consist of movies from at least two fields of view containing between 5 and 10 microtubules each.

Image using the 405 nm laser to determine the locations of the microtubules. Preferably at the start and end of the experiment.

Single-molecule motility assay analysis recommendation:
Kymographs were generated from motility movies and quantified for run lengths, percent motility, and velocity using ImageJ (NIH). Specifically, maximum-intensity projections were generated from time-lapse sequences to define the trajectory of particles on a single microtubule. The segmented line tool was used to trace the trajectories and map them onto the original video sequence, which was subsequently re-sliced to generate a kymograph. Motile and immotile events (> 1 sec) were manually traced. Bright aggregates, which were less than 5% of the population, were excluded from the analysis. Run length measurements were calculated from motile events only. For percent motility per microtubule measurements, motile events (> 1 sec and > 1µm) were divided by total events per kymograph. Velocity measurements were calculated from the inverse slopes of the motile event traces (> 1 sec and > 1µm) only. Statistical analyses were performed in Prism8 (Graphpad).
Materials
Recommended Equipment and Setup:
This single-molecule imaging experiment was originally performed using total internal reflection fluorescence (TIRF) microscopy with an inverted microscope (Nikon, Ti-E Eclipse) equipped with a 100x 1.49 N.A. oil immersion objective (Nikon, Plano Apo), and a MLC400B laser launch (Agilent), with 405 nm, 488 nm, 561 nm and 640 nm laser lines (561 and 640 nm laser lines are not needed for this version of the experiment). Excitation and emission paths were filtered using single bandpass filter cubes (Chroma), and emitted signals were detected with an electron multiplying CCD camera (Andor Technology, iXon Ultra 888). Illumination and image acquisition were controlled with NIS Elements Advanced Research software (Nikon), and the xy position of the stage was controlled with a ProScan linear motor stage controller (Prior).


Required Buffers:

Streptavidin Buffer:

  • Concentration1 mg/mL Streptavidin
  • Concentration30 millimolar (mM) HEPES pH 7.4
  • Concentration2 millimolar (mM) MgOAc
  • Concentration1 millimolar (mM) EGTA
  • Concentration10 % Glycerol

Motility Assay Buffer:

  • Concentration30 millimolar (mM) HEPES pH 7.4
  • Concentration50 millimolar (mM) KOAc
  • Concentration2 millimolar (mM) MgOAc
  • Concentration1 millimolar (mM) EGTA
  • Concentration10 % Glycerol
  • Concentration1 millimolar (mM) DTT
  • Concentration20 micromolar (µM) Taxol

Motility Assay Buffer with casein:

  • Concentration30 millimolar (mM) HEPES pH 7.4
  • Concentration50 millimolar (mM) KOAc
  • Concentration2 millimolar (mM) MgOAc
  • Concentration1 millimolar (mM) EGTA
  • Concentration10 % Glycerol
  • Concentration1 millimolar (mM) DTT
  • Concentration20 micromolar (µM) Taxol
  • Concentration1 mg/mL casein

LRRK2 Buffer:

  • Concentration20 millimolar (mM) HEPES pH 7.4
  • Concentration80 millimolar (mM) NaCl
  • Concentration0.5 millimolar (mM) TCEP
  • Concentration5 % Glycerol
  • Concentration2.5 millimolar (mM) MgCl2
  • Concentration20 micromolar (µM) GDP
Safety warnings
For hazard information and safety warnings, please refer to the SDS (Safety Data Sheet).
Before start
Please take notice of the buffer preparation in section 'Materials'.
Make sure that you have labeled taxol-stabilized microtubules available. See the protocol here.
Create microscope slides:
Create microscope slides:
1h 11m
1h 11m
Adhere Biotin-PEG-functionalized coverslips (Microsurfaces) to a microscope slide using double-sided scotch tape, creating 4 channels per slide.
Add the streptavidin buffer to each channel and incubate for Duration00:03:00 .
3m
Wash twice with Motility Assay buffer.
Wash
Add a 1:150 dilution of taxol-stabilized microtubules (Amount19 µL per channel) and incubate for Duration00:03:00 .
See https://dx.doi.org/10.17504/protocols.io.bp2l6bdedgqe/v1 for making taxol-stabilized microtubules.
3m
Incubation
Wash twice with LRRK2 buffer. Add more buffer if necessary to prevent drying out.
Wash
Prepare LRRK2:
Prepare LRRK2:
1h 11m
1h 11m
Prepare a Concentration1 micromolar (µM) solution of LRRK2RCKW in a cold LRRK2 buffer. Centrifuge through a 0.1 μm PVDF filter to remove aggregates. Calculate the new effective concentration. Usually around Concentration500 nanomolar (nM) -Concentration700 nanomolar (nM) after centrifugation.
Centrifigation
Create a working aliquot of LRRK2 in the desired concentration (ex. Concentration25 nanomolar (nM) -Concentration100 nanomolar (nM) ) in the LRRK2 buffer at TemperatureRoom temperature (recommended volume of Amount25 µL ). If adding inhibitors, add them now with DMSO. Incubate for Duration00:10:00 at TemperatureRoom temperature .
10m
Incubation
Next steps:
Next steps:
5m
5m
Add LRRK2RCKW sample to the channel (Amount19 µL ). Incubate for Duration00:05:00 . Prepare next step while waiting.
5m
Incubation
Wash twice with the motility assay buffer supplemented with Concentration1 mg/mL casein .
Wash
Prepare kinesin:
Prepare kinesin:
Make a Concentration4 nanomolar (nM) solution of K560-GFP in the Motility Assay buffer with casein supplemented with an oxygen scavenger system (Concentration0.4 % glucose , Concentration45 µg/mL glucose catalase (Sigma-Aldrich), and Concentration1.15 mg/mL glucose oxidase (Sigma-Aldrich)), Concentration71.5 millimolar (mM) beta-mercaptoethanol and Concentration1 millimolar (mM) ATP .
Mix
Next steps:
Next steps:
Add Amount19 µL kinesin mixture to each chamber.

Image slide.
Citations
Deniston CK, Salogiannis J, Mathea S, Snead DM, Lahiri I, Matyszewski M, Donosa O, Watanabe R, Böhning J, Shiau AK, Knapp S, Villa E, Reck-Peterson SL, Leschziner AE. Structure of LRRK2 in Parkinson's disease and model for microtubule interaction.
https://doi.org/10.1038/s41586-020-2673-2